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Background: Autosomal dominant polycystic kidney disease (ADPKD) is an inherited disorder that is characterized
by the development of cysts in the kidneys and other organs. Urinary protein excretion is usually less than 1 g/day,
and ADPKD is rarely associated with nephrotic syndrome or rapidly progressive glomerulonephritis (RPGN). To date,
myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis
(CrGN) has not been reported in a patient with ADPKD.
Case presentations: We report two cases of MPO-ANCA positive ADPKD. A 60-year-old Japanese woman (case 1)
and a 54-year-old Japanese woman (case 2) presented with RPGN featuring severe proteinuria and microscopic
hematuria. In both patients percutaneous needle biopsy of the kidney revealed MPO-ANCA-associated CrGN with a
paucity of glomerular immunoglobulin staining. Each patient received intravenous methylprednisolone for 3 days,
followed by oral prednisolone. Case 1 showed gradual improvement and has not progressed to end-stage renal
disease (ESRD), but case 2 developed ESRD requiring hemodialysis within one month despite treatment.
Conclusion: These are the first two reported cases of MPO-ANCA-associated CrGN in patients with ADPKD. Our
experience suggests that serial measurement of the ANCA titer and renal biopsy should be considered for accurate
diagnosis and appropriate treatment of ADPKD patients who present with proteinuria, hematuria, and rapid decline
of renal function.
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Autosomal dominant polycystic kidney disease (ADPKD)
is a common inherited disorder that is characterized by
the development of cysts in the kidneys and other organs,
with its prevalence estimated to be between 1 in 400 and
1 in 1000 individuals. In most patients, urinary protein
excretion is less than 1 g/day and renal function is
maintained within the normal range despite the relentless
growth of cysts, until they reach the fourth to sixth decade
of life. Then renal function starts to decline, with the
glomerular filtration rate decreasing by approximately
4.4–5.9 ml/min/year [1,2]. Therefore, detection of nephrotic* Correspondence: k-sumida@toranomon.gr.jp
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reproduction in any medium, provided the orrange proteinuria, hematuria, and/or a rapid decline of
renal function in ADPKD patients should suggest
the possibility of complicating glomerular disease [3].
Although various histopathological lesions have been
reported in ADPKD patients, including focal segmental
glomerulosclerosis (FSGS), membranous nephropathy,
minimal change disease, and immunoglobulin A (IgA) ne-
phropathy [4-18], myeloperoxidase (MPO)-antineutrophil
cytoplasmic antibody (ANCA)-associated crescentic
glomerulonephritis (CrGN) has not been reported so far.
Here we describe the first two cases of MPO-ANCA-
associated CrGN in ADPKD patients who presented with
rapidly progressive glomerulonephritis (RPGN), severe
proteinuria, and microscopic hematuria.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Abdominal computed tomography shows an enlarged
liver and kidneys with multiple cysts in case 1.
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Case 1
In September 2010, a 60-year-old Japanese woman was
admitted to a general hospital with the symptom of
abdominal pain and nausea. ADPKD had been diagnosed
in 2000 when she had a slightly elevated serum creatinine
level (1.3 mg/dL) without proteinuria or hematuria. Her
medical history included hypertension that was being
treated with an antihypertensive agent (losartan potassium
50 mg/day).
On admission, her temperature was 36.2°C and her
blood pressure was 117/70 mmHg. Physical examination
was normal, except for bilateral palpable lumpy kidneys.
Hematology tests indicated a white blood cell count of
4.6 × 109/L, hemoglobin of 9.0 g/dL, and platelet count
of 24.3 × 109/L. Blood urea nitrogen was 46 mg/dL, serum
creatinine was 4.5 mg/dL, serum albumin was 3.7 g/dL,
C-reactive protein (CRP) was 0.96 mg/dL, rheumatoid
factor was 16 U/mL, antinuclear antibody was 1:40 (normal
range: <1:80), and MPO-ANCA was 393 EU (normal
range: <20 EU). Serum IgG, IgA, IgM, total hemolytic
complement (CH50), and complement components
were normal. Cryoglobulinemia, anti-glomerular basement
membrane (GBM) antibody, and anti-proteinase 3 (PR3)
antibody were negative. Urinalysis showed proteinuria
(2.03 g/day). The sediment contained over 100 dysmorphic
red blood cells (RBCs) per high power field (HPF) with
RBC casts and 1 to 5 white blood cells (WBCs)/HPF.
Creatinine clearance (CCr) was 10.2 ml/min. Blood and
urine cultures were negative. The chest X-ray film and
computed tomography (CT) scan were normal. Abdominal
ultrasonography (US) and CT showed enlargement of the
liver and kidneys with multiple cysts (Figure 1).
MPO-ANCA-associated RPGN was suspected and the
patient was treated with prednisolone (PSL) at 35 mg/day.
Within one month, her serum creatinine declined to
3.2 mg/dL, but proteinuria and hematuria persisted at
3.50 g/day and 10 to 30 RBCs/HPF, respectively. She was
referred to our hospital for further examination and treat-
ment. To make a definite diagnosis, percutaneous needle
biopsy of the kidney was performed in October 2010.
On light microscopy, 19 glomeruli were observed, with
6 being sclerotic. Of the 13 nonsclerotic glomeruli, 3
showed fibrous crescent formation and the others were
relatively preserved with segmental capillary wall wrinkling.
Severe inflammatory interstitial fibrosis and tubular
atrophy were also observed, along with mild hyaline
arteriolosclerosis and moderate intimal thickening of
the interlobular artery (Figure 2A and B). There was no
vasculitis of the arteries or arterioles. Immunofluorescence
microscopy showed negative staining of the glomeruli.
Electron microscopy showed no immune complex deposits.
It was considered that these findings reflected the status
after treatment of MPO-ANCA-associated CrGN withPSL. She was given intravenous methylprednisolone
(500 mg/day) for 3 days, followed by oral PSL (20 mg/day),
resulting in further improvement of her renal func-
tion as well as the proteinuria and hematuria. In July
2012 (21 months after the onset), her serum creatinine
was 2.8 mg/dL, the MPO-ANCA titer was 25 EU, and
proteinuria was 0.2 g/day without hematuria. She is being
maintained on 5 mg/day of oral PSL.
Case 2
The patient was a 54-year-old Japanese woman, in whom
ADPKD had been diagnosed in 2002 when she had a
slightly elevated serum creatinine level (1.3 mg/dL) without
proteinuria or hematuria. In September 2010, serum
creatinine was increased to 1.9 mg/dL. It rose further to
5.7 mg/dL with proteinuria (2.9 g/gCr) and hematuria
by November 2010, and a high MPO-ANCA titer of 210
EU (normal range: <20 EU) was also detected at that time.
She was admitted to our hospital for further evaluation.
Her medical history included subarachnoid hemorrhage at
the age of 36 years.
On admission, her temperature was 36.8°C and her
blood pressure was 148/80 mmHg. Physical examination
was normal, except for bilateral palpable lumpy kidneys.
Hematology tests revealed a white blood cell count of
6.5 × 109/L, hemoglobin of 7.9 g/dL, and platelet count
of 20.4 × 109/L. Blood urea nitrogen was 83 mg/dL,
serum creatinine was 5.7 mg/dL, serum albumin was
3.0 g/dL, CRP was 1.1 mg/dL, antinuclear antibody was
Figure 2 Light microscopy findings on renal biopsy in case 1.
(A) Severe inflammatory interstitial fibrosis and tubular atrophy with
mild hyaline arteriolosclerosis and moderate intimal thickening of
the interlobular artery. (Masson-trichrome stain; original
magnification × 40). (B) The glomeruli show fibrous crescent
formations and disruption of Bowman’s capsule with periglomerular
fibrosis. (Periodic acid-Schiff stain; original magnification × 400).
Figure 3 Abdominal computed tomography shows an enlarged
liver and kidneys with multiple cysts in case 2.
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was 210 EU. Serum IgG, IgA, IgM, CH50, and components
of complement were normal. Investigations for cryo-
globulinemia, anti-GBM antibody, and anti-PR3 antibody
were negative. Urinalysis showed proteinuria (3.85 g/day)
and the sediment contained over 100 dysmorphic RBCs/
HPF along with RBC casts and 1 to 5 WBCs/HPF.
CCr was 15.2 ml/min. Blood and urine cultures were
negative. The chest X-ray film and CT were normal,
while abdominal US and CT showed enlargement of the
liver and kidneys with multiple cysts (Figure 3).
Percutaneous renal biopsy was performed. On light
microscopy, 9 glomeruli were observed, none of which
were sclerotic. Six of the 9 glomeruli showed cellular
crescent formation. Moderate inflammatory interstitial
fibrosis and tubular atrophy were observed, as well as
focal cystic and papillary changes of the tubules that are
characteristic of polycystic kidney disease (Figure 4A and
B). There was no evidence of vasculitis affecting thearteries or arterioles. Immunofluorescence microscopy
showed negative staining of the glomeruli and electron
microscopy detected no immune complex deposits. These
results supported a diagnosis of MPO-ANCA-associated
CrGN with ADPKD. Intravenous methylprednisolone
(500 mg/day) was given for 3 days immediately after the
renal biopsy, followed by 30 mg/day of oral PSL. However,
her renal function continued to deteriorate. Even three
courses of plasma exchange failed to suppress disease
activity and exacerbation of renal dysfunction led to
end-stage renal disease (ESRD) requiring hemodialysis
within one month of admission. In July 2012 (20 months
after the onset), she was on maintenance hemodialysis
and was receiving oral PSL (2 mg/day) with no recurrence
of vasculitis. At that time, CRP was 0.3 mg/dL and the
MPO-ANCA titer was less than 10 EU.
Discussion
The most common causes of a sudden decline of
renal function in ADPKD patients are volume depletion,
obstruction, and infection [19]. Hematuria (which is
usually gross) occurs at some time during the course in
35 to 50% of patients with ADPKD and may even be the
presenting symptom of this disease [20,21]. In contrast to
macroscopic hematuria, microscopic hematuria (especially
with RBC casts) is rarely seen in ADPKD patients.
Therefore, the detection of proteinuria in the nephrotic
range, hematuria with RBC casts, and/or a rapid decline of
renal function in ADPKD patients suggests the possibility
of superimposed glomerular diseases.
Seventeen cases of ADPKD associated with glomerular
disease that was evaluated by renal biopsy have been
Figure 4 Light microscopy findings on renal biopsy in case 2. (A) Moderate inflammatory interstitial fibrosis and tubular atrophy, as well as
focal cystic and papillary changes of the tubules that are characteristic of polycystic kidney disease. (Masson-trichrome stain; original
magnification × 40). (B) The glomeruli show cellular crescent formation and partial disruption of Bowman’s capsule. (Periodic acid-Schiff stain;
original magnification × 400).
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these 17 patients, 4 had FSGS and this represented the
most common histological subtype associated with
ADPKD [3-6], followed by 3 cases of membranous
nephropathy [7-9], 2 cases each of minimal change disease
[10,11], IgA nephropathy [12,13], and post-infectious
mesangial proliferative glomerulonephritis [14,15], and one
case each of membranoproliferative glomerulonephritis
[15], mesangioproliferative glomerulonephritis [16],
diabetic glomerulosclerosis [17], and crescentic glomer-
ulonephritis [18]. The high incidence of FSGS suggests
that glomerular hyperfiltration could play an important
role in the development of FSGS and heavy proteinuria
in ADPKD patients, while FSGS may in turn be important
for progression to ESRD in a subgroup of ADPKD
patients [3]. However, it is difficult to be certain
whether these glomerular diseases are coincidental or
whether they demonstrate a specific pathogenetic
relationship with ADPKD.There has only been one report of ADPKD associated
with RPGN due to CrGN, which was a case described by
Licina et al. in 1981 [18]. Because the patient had acute
renal failure and microscopic hematuria with RBC casts,
they performed open renal biopsy and this led to the
diagnosis of idiopathic crescentic RPGN. The actual
diagnosis could have been ANCA-associated CrGN,
but this case occurred before the discovery of ANCA
by Davies et al. in 1982 [21]. In Asian countries, the
prevalence of MPO/PR3-ANCA in patients with ANCA-
associated vasculitis (AAV) is much higher than in
European countries [22,23], but there has been no report
about MPO-ANCA-associated vasculitis in ADPKD
patients or any association between MPO-ANCA and
ADPKD. Regarding the pathogenesis of AAV, recent
studies have indicated a triggering role of microbial
factors. In particular, Staphylococcus aureus carrier
status and infection with Gram-negative bacteria could
contribute to the onset and persistence of AAV [24,25].
Table 1 List of patients who had ADPKD and glomerular disease with biopsy-proven renal histopathology
Patient no. First author
(Ref. No.)













1 Murphy [4] 44 M 3.4 9.9 7 NA O FSGS ACEi 32 months HD
2 Montoyo [5] 35 M 2.4 3.5 14 NA O FSGS ACEi 3 months HD
3 Dionisio [6] 58 M NA Slight increase 8 NA O FSGS Steroid, ACEi 6 years HD
4 Contreas [3] 65 F 3.7 1.2 5.8 NA O FSGS ACEi 3 years CCr 32 ml/min, proteinuria
5.5 g/day
5 Shikata [7] 53 F 2.2 1.0 6 3-5 O MN Pred, NA NA
6 Saxena [8] 22 M 2.5 0.8 6 occasional NA MN NA NA NA
7 Peces [9] 38 M NA 1 11.8 NA P MN ARB, Pred, MMF 10 years CCr 114 ml/min, proteinuria
0.4 g/day
8 Nakahama [10] 14 M 1.7 CCr 114 ml/min 23.0 A few P MCD MP, Pred 1 months Remission
9 Kuroki [11] 18 F 3.4 0.9 5.4 0 O MCD Pred, CPA 6 months Remission
10 Panisello [12] 67 M 4.4 6.3 4.2 10 O IgAN NA 3 months Cr 9.2 mg/dL
11 Hiura [13] 70 M 2.2 1.69 5.76 >100 O IgAN Pred 5 years CCr 40.9 ml/min, proteinuria
0.08 g/day
12 D’Cruz [14] 35 M 3.0 1.7 4.67 8-10 O PIGN ARB 12 weeks Remission
13 Villar [15] 28 M NA 5.7 4.7 NA O PIGN ACEi 1 year PD
14 Villar [15] 25 M 2.7 5.5 12 NA O MPGN MP 10 months PD
15 Seyrek [16] 56 F NA NA 0.5 many NA MesGN Pred 1 year Remission
16 Hariharan [17] 44 M 2.5 1.35 11 10-12 P IDGS NA 1 year HD
17 Licina [18] 69 F NA 5 (3+) Many O CrGN MP, Pred 3 months Cr 2.4 mg/dL
18 Present case 1 60 F 3.7 4.5 2.03 >100 P ANCA-associated CrGN MP, Pred 21 months Cr 2.8 mg/dL, proteinuria
0.2 g/day
19 Present case 2 54 F 3.0 5.7 3.85 >100 P ANCA-associated CrGN MP, Pred, PEX 1 month HD
NA, not available; P, percutaneous biopsy; O, open surgical biopsy; FSGS, focal segmental glomerulosclerosis; MN, membranous nephropathy; MCD, minimal change disease; IgAN, IgA nephropathy; PIGN, post-
infectious mesangial proliferative glomerulonephritis; MPGN, membranoproliferative glomerulonephritis; MesGN, mesangioproliferative glomerulonephritis; IDGN, intercapillary diabetic glomerulosclerosis; CrGN,
crescentic glomerulonephritis; ANCA, antineutrophil cytoplasmic antibody; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; Pred, prednisone; MMF, mycophenolate mofetil; MP,
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associated membrane protein-2 (hLAMP-2) in patients with
pauci-immune necrotizing glomerulonephritis (NCGN)
who were positive for PR3-ANCA or MPO-ANCA.
They proposed that such autoantibodies might contribute
to renal injury because the antigen is expressed on the
plasma membrane of glomerular endothelial cells.
They also revealed that an immunodominant epitope
of hLAMP-2 showed strong homology with FimH, an
adhesion protein of Gram-negative bacteria such as
Escherichia coli and Klebsiella pneumonia, and suggested
that Gram-negative infection might induce pathogenic
autoantibodies in a susceptible host, resulting in NCGN
[25]. Although bacterial infection was not detected in our
two patients, a subclinical Gram-negative infection (such
as a latent cyst infection) could possibly have contributed
to the pathogenesis of MPO-ANCA-associated CrGN.
In ADPKD patients, the presence of multiple cysts
in both kidneys is considered as a contraindication to
percutaneous renal biopsy due to the presumed risk of
complications and difficulty in obtaining suitable tissue
for diagnosis. Indeed, only 3 of the 17 patients (17.6%)
listed in Table 1 underwent percutaneous renal biopsy,
while 13 patients (76.5%) had open surgical biopsy. In
the remaining one patient, the details of the procedure
were unknown. In our two cases, abdominal computed
tomography was initially performed to confirm the
site of residual renal parenchyma, after which percutan-
eous needle biopsy was performed without complications.
This enabled us to make a definite diagnosis of MPO-
ANCA-associated CrGN and to provide appropriate
corticosteroid therapy with confidence. Although our
experience with percutaneous needle renal biopsy is
too limited to recommend its widespread adoption,
US-guided needle biopsy is less invasive and fewer com-
plications, so it is worth considering when renal biopsy is
required in ADPKD patients.Conclusion
To the best of our knowledge, this is the first report
about MPO-ANCA-associated CrGN in ADPKD patients.
These two cases emphasize that detection of proteinuria,
hematuria (especially with RBC casts), and a rapid decline
of renal function in ADPKD patients should suggest the
possibility of glomerular disease. Then serial measurement
of ANCA and renal biopsy should be considered to allow
accurate diagnosis and appropriate treatment.Consent
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